{
  "id": "a2476382516608dc",
  "title": "At ASH , GSK Top Cancer Exec Discusses the FDA Different Take on Multiple Myeloma Drug Blenrep",
  "description": "20251209T044500Z",
  "content": "",
  "source": "medcitynews.com",
  "source_url": "https://medcitynews.com/2025/12/gsk-cancer-hesham-abdullah-blenrep-multiple-myeloma-adc-fda-ash/",
  "published_at": "20251209T044500Z",
  "fetched_at": "2025-12-10T00:22:54.894572+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug",
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://medcitynews.com/2025/12/gsk-cancer-hesham-abdullah-blenrep-multiple-myeloma-adc-fda-ash/",
    "url_mobile": "",
    "title": "At ASH , GSK Top Cancer Exec Discusses the FDA Different Take on Multiple Myeloma Drug Blenrep",
    "seendate": "20251209T044500Z",
    "socialimage": "https://medcitynews.com/wp-content/uploads/sites/7/2025/12/GSK_HeshamAbdullah.jpg",
    "domain": "medcitynews.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}